Tag: raltegravir
20
OctoberRaltegravir for Post-Exposure Prophylaxis: Is It a Viable Option?
Raltegravir is still used for HIV post-exposure prophylaxis, but dolutegravir is now preferred due to simpler dosing and better adherence. Learn when raltegravir remains the right choice.
Recent posts
-
26 Jan 2026
Clinical Trial Eligibility: How Biomarkers Shape Inclusion Criteria in Cancer Care
-
9 May 2026
Alzheimer’s Disease: Memory Loss, Progression Stages, and 2026 Treatments
-
28 Sep 2025
Samsca (Tolvaptan) vs Alternative Hyponatremia Drugs: Pros, Cons & Best Fit
-
9 Jun 2026
Pregnancy Medication Risks by Trimester: A Timing Guide for Safer Choices
-
19 Dec 2025
PDE5 Inhibitors and Nitrates: How Their Interaction Causes Dangerous Blood Pressure Drops